- Thermo Fisher Scientific Signs Long-term, Exclusive U.S. Distributor Agreement with Aesku.Group
- Imbio to be Acquired by 4DMedical Creating Comprehensive Cardiothoracic Image Analysis Portfolio
- Graphene Nanotubes Revolutionize Protective Film Technology: Ultrathin, Permanently Conductive PSA
- Optibrium’s Quantum Mechanics and Machine Learning Methods Predict Routes of Drug Metabolism
- Future-Proofing Medical Labs
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States, Medical Device News Magazine has established itself as one of the foremost and most trusted sources of comprehensive updates and insights within the medical device and biotech industries. Our publication is committed to delivering timely and relevant information, making it a go-to resource for professionals and enthusiasts alike.
Medical Device News Magazine is easily accessible to readers 24/7/365, allowing you to stay informed at your convenience, and it presents content that is a fast and engaging read. We take pride in offering valuable insights in a format that can be consumed quickly, ensuring that our audience stays ahead of the curve.
Furthermore, if you are interested in expanding your reach and visibility within this dynamic field, we encourage you to inquire about advertising opportunities with us.
"Medical Device and Biotechnology Sector News: Essential Key Insights and Noteworthy Developments that are Shaping the Future"
CEYEBER Develops First-Ever Intraocular Smart Lens: The Third Eye
“We’re very excited about our revolutionary solution for age related macular degeneration (AMD), accommodative vision correction and the long-term prevention of blindness. According to recent estimates, close to 200 million people globally are affected by AMD which is expected to grow to 288 million people by 2040. CEYEBER will have a profound impact on the quality of life and vision for millions of people worldwide,” explained Robert Edward Grant, Founder and CEO of CEYEBER.
MicroTransponder Secures CMS Transitional Pass-Through Status & New Technology Add-On Payment for Its Breakthrough Stroke Rehabilitation System, Vivistim
The Vivistim Paired VNS System is an FDA Breakthrough Device that was granted pre-market authorization (PMA) approval on August 27, 2021. Unlike other neurostimulation technologies, the Vivistim System is used in conjunction with rehabilitation therapy to help ischemic stroke survivors who have chronic arm and hand deficits improve their upper limb function.
Medical iSight Establishes Neuroradiology Collaboration with NYU Langone Health
Medical iSight CEO, Justin Hall-Tipping, commented: “We are delighted to be working with NYU Langone Health and their world-class doctors to advance our groundbreaking interventional software and deliver on our vision to unite surgical digital information within a single cognitive platform, to make it universally accessible, thereby resulting in better patient outcomes.”
Smith+Nephew Receives Innovative Technology Designation from Vizient for LEAF™ Patient Monitoring System
“We are very proud to receive the Innovative Technology designation from Vizient. Pressure injuries are the only hospital acquired complication on the rise in the US, costing roughly $11B in preventable treatments, with dire impact to those patients affected,” said Paolo Di Vincenzo, Senior Vice President US Commercial, Advanced Wound Management for Smith+Nephew. “We will not settle until we’ve solved this challenge and are excited for the role our LEAF Patient Monitoring System will play – fast becoming a standard of patient care in the U.S. and reducing facility costs.”
Innovative Solutions for Today's Challenges, Secured Funding for a Brighter Future
Lauxera Capital Partners Invests €10m In Matrix Requirements
Founded in 2014, Matrix Requirements supports the R&D, Regulatory Affairs and Quality departments of MedTech companies by providing specialized digital tools for medical device design, traceability, quality management and regulatory compliance.
Able Innovations Works to Transform Frontline Healthcare with USD $6MM in Funding
Able Innovations is using robotics to transform processes for healthcare staff by incorporating safety and dignity into a routine procedure that affects providers and patients.
Industry Expert Byline
Reimagining CRM: What’s Next for Medtech Commercial Success | By Akshay Kapadia, CEO and Founder, Conexus Solutions, Inc.
Success depends on more than just choosing the right CRM platform; it requires aligning that platform with optimized business processes, a clear data strategy, and long-term commercial goals. When all of these elements work together, the CRM platform becomes a powerful tool to support growth, innovation, and sustained value.
Ariceum Therapeutics’ Targeted Radiopharmaceutical 177Lu-satoreotide Exhibits Promising Clinical Response and Good Tolerability Profile in Patients with Advanced Neuroendocrine Tumours
Satoreotide combines Ariceum’s proprietary peptide satoreotide – a first-in-class and best-in-class antagonist of the somatostatin receptor 2 (SSTR2) – with the radioactive isotope ‘payload’ 177Lutetium. SSTR2 is a cell surface protein often overexpressed in certain cancers, including NETs and small cell lung cancer (SCLC).
New Hot Start Isothermal Mixes Boost Sensitivity, Specificity, and Speed of DNA Target Detection
Isothermal mixes are important in a range of isothermal amplification applications, including whole genome amplification, point-of-care assay development and testing, and strand displacement amplification for synthetic biology. However, a common issue with isothermal mixes is non-specific amplification — where primers bind to unintended DNA targets — because amplification often takes place at a fixed temperature which may favour non-specific primer interactions, contrary to PCR. Isothermal mixes can also lead to primer dimer formation, where primers associate with each other and are extended by the polymerase.
Comprehensive Insights into Medical Device and Biotechnology Company Mergers and Acquisitions Trends and Strategies
SmartBreast Acquires Molecular Breast Imaging Assets from GE Healthcare
SmartBreast notes the Discovery NM750b is installed at scores of sites worldwide. SmartBreast will manufacture, market and distribute the MBI scanner, rebranded as “EVE CLEAR SCAN e750.
Schivo Acquires Supreme Screw Products – Strengthens Position as a Leader in Medical and Life Sciences Technologies
Schivo notes Supreme Screw Products, Inc. is a leading supplier of precision machining, laser processing, and assembly services for the medical device market.
FDA Medical Device Updates
Our Experts - Byline Articles
Medical Imaging Technologies and Their Impact on Modern Healthcare
Healing Headlines, Transforming Lives: Hospitals in the News
The Role of Medical Imaging Equipment in the Diagnosis and Treatment
This article will explore the different types of medical imaging equipment and their importance in modern healthcare.
